Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

about

Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

Item

http://www.wikidata.org/entity/Q38932097

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

@en

type

Item

label

Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

@en

prefLabel

Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

@en

P1476

Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential.

@en

P2093

Bindee Kuriya

http://www.w3.org/2001/XMLSchema#string

Ed Keystone

http://www.w3.org/2001/XMLSchema#string

Marc D Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

JAKs and STATs in immunity, immunodeficiency, and cancer.

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment.

JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.

Tofacitinib: a review of its use in adult patients with rheumatoid arthritis.

Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050.

Baricitinib in Patients with Refractory Rheumatoid Arthritis.

The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers.

P304

37-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X16687481

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28255337

http://www.w3.org/2001/XMLSchema#string

P932

5315227

http://www.w3.org/2001/XMLSchema#string